India's software #COVID19 vaccine software CoWIN (designed by Trigyn Technologies, hosted on Amazon Web Services) has been hitting snags. @PratapVikramSin@OBanerji and me find out what doctors, health workers are facing on ground & how this will effect vaccination drive #thread
Doctors receive erroneous text messages saying vaccination has been delayed (later getting a call saying its actually not), another scheduling at a later date when doc has already got his dose #CowinApp#CoWIN - Graphic by @ShirtShanks
Ministry of Health & that of IT has been super secretive about CoWIN's making, we didn't know beyond UNDP's involvement in making the app, until sources told us that Trigyn Tech and Amazon Web Services are involved, despite reservations expressed by Ministry of Health.
CoWIN wants to integrate channels of supply chain management to beneficiary registration as also get AADHAR to make beneficiary's unique health ID all through one motive - #COVID19 vaccine - Graphic by @ShirtShanks
UNDP may have spent close to Rs 25 crore for CoWIN with Amazon charging close to Rs 20 crore when National Informatics Centre's (make in india) cloud MeghRaj could have halved cost. Trigyn gets Rs 2-4 cr for CoWIN. [Free] story - the-ken.com/story/building…@CatizenKane@jananevenk
• • •
Missing some Tweet in this thread? You can try to
force a refresh
On 1 pm - Sunday - over six #Covaxin trial participants (gas tragedy victims) from poor neighbourhoods behind abandoned Union Carbide factory in Bhopal huddled into a tiny zoom call screen. Following death of 1 participant they recall how they were 'lured' to take the jab #thread
In Dec, a public announcement vehicle entered their narrow bylanes and blared - “Corona ka tika lagao, sade saatso rupaie paao,” loosely translated into get an injection against Covid and earn Rs 750. As the month went by, a few participants started experiencing adverse events.
A day after Bharat Biotech said a Bhopal gas tragedy victim's death who participated in clinical trials was 'unrelated' to vaccine, this has opened up a Pandora's box on ethics and legal issues surrounding clinical trials #COVID19#vaccine
Chances are if you are in infected with #COVID19 & have mild symptoms, you will be asked to isolate at home. You are not turning breathless but running a mild fever. You freak out. What next? And enrol for a private hospital's home care package. Here is what follows - Thread -
During the course of reporting this story, we found a patient paying close to Rs 40K for home care package, drugs, diagnostic tests, more tests, CT scans while not developing any complications. But here's what beat every thing. A single set of blood test cost Rs 20k!
We found a wide range of prices at which leading hospitals are offering homecare from Max to Medanta, Fortis and Apollo, the range of costs is as wide as between Rs 4500 to over Rs 21000 (but lab tests and drugs cost additionally of course) Graphic by @ShirtShanks
#Thread on clinical trials of #Itolizumab - 20 patients received the drug, another 10 patients (three died) received supportive care, four doses were given, 32 patients were randomized, two patients discontinued. says Dr Sandeep Athalye @Bioconlimited
Predominantly male participation with comorbidities like diabetes, thyroid and blood pressure issues. All 20 patients who were given the drug died. In the arm which did not receive the drug, 3 patients died and 2 needed invasive ventilation before they died. #Itolizumab
Key markers for inflammation IL 6 aand TNF alpha came down in those who received the drug. Serum Ferritin levels also came down. Even D Dimer markers which indicate clotting or coagulopathy #Itolizumab
@ICMRDELHI must make the validation protocol of rapid antibody testing kits in light of these kits being deemed 'faulty,' after import of nearly five lakh at close to Rs 26 crore. Read what this means for centre/states here - thehindubusinessline.com/news/analysis-…@businessline#Thread
Everything that @ICMRDELHI did wrong while going in for the Chinese kits. It had been raising purchase orders since April 3, but no company would supply. Read how procurements were delayed in this story on April 15 - thehindubusinessline.com/news/national/…@businessline
On April 16, @ICMRDELHI said that the kits had arrived from China. 5 lakh of them. From Guangzhou Wondfo Biotech, Zhuhai Livzon Diagnostics. Another 1.5 lakh from a company in Shenzhen were on their way - thehindubusinessline.com/news/rapid-ant…@businessline
So went on in #Covid_19india press briefing yesterday -In the light of sharp spike of cases of novel coronavirus (COVID19), @ICMRDELHI to release mathematical estimations of the best and the worst possible scenarios @businessline@srinivasanravi
which could play out over the next few months as far as the number of new cases are concerned. By Sunday evening, India had recorded 360 confirmed cases of COVID19, of which 24 recovered, 7 died. Spike of 124 cases as compared to the previous day.
According to academic estimate modelings, India could stare at cases running into few lakhs and few thousands of deaths. #Covid19India#Covid19India
First COVID-19 death in #India - Thread - Death of a 76 year old male from Karnataka is confirmed by @MoHFW_INDIA to be caused due to co-morbidity and has also tested positive for COVID-19. @businessline@srinivasanravi @RichaMishraBL
The details of the case are as follows:
He visited Saudi Arabia from 29th January 2020 to 29th February 2020. He was a known case of Hypertension and Asthma. He reached back to Hyderabad on 29th February and went to Kalaburgi.